Literature DB >> 15448705

Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.

Jingchao Li1, Young-Min Ha, Na-Youn Kü, Se-Young Choi, Sung J Lee, Seog B Oh, Joong-Soo Kim, Jong-Ho Lee, Eun B Lee, Yeong W Song, Kyungpyo Park.   

Abstract

Sjogren's syndrome (SS) is a systemic autoimmune disease that involves reduced salivary secretions. Recently, circulating autoantibodies from SS patients against the type 3 muscarinic cholinergic receptor (M3R) has been reported in the sera of SS patients. However, the role of these autoantibodies in the development of SS has not been elucidated. In this study, purified IgG was obtained from the sera of 11 SS patients, and its inhibitory effect on the M3R of the salivary glands was evaluated using RT-PCR, microspectrofluorimetry, immunohistochemistry, and Western blot analysis. Stimulation with carbachol (CCh) evoked a [Ca2+]i transient in the fura-2 loaded HSG cells. However, pretreatment of the cells with SS IgG (0.5 mg/ml) for 12 or 24 h significantly reduced the magnitude of the CCh-induced [Ca2+]i transient (CICT). We found that the magnitude of CICT was decreased by 62-45% when cells were pretreated with the SS IgG. However, the [Ca2+]i response to ATP was not altered by the pretreatment of SS IgG. The effect of SS IgG on CICT was abrogated by the inclusion of excessive competitive peptides that encode the amino-acid sequence of M3R, which was not recapitulated by nonspecific peptides. The inhibitory effect of SS IgG on the aquaporin (AQP)-5 expression was also examined. After confirming the apical localization of AQP-5 along with its increase by pilocarpine (10(-5) M), we examined whether SS IgG had an effect on pilocarpine-induced AQP-5 trafficking to the apical membrane (APM) using rat parotid acinar cells. After incubating the cells with SS IgG for 12 h, the amount of pilocarpine-induced AQP-5 significantly decreased compared to the control groups. In conclusion, autoantibodies from the SS patients inhibit the function of the human M3R that is mediated by Ca2+ mobilization and AQP-5 trafficking. Our results could partly explain the underlying mechanisms of glandular dysfunction and associated features of impaired autonomic function in SS patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448705     DOI: 10.1038/labinvest.3700173

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

Review 1.  Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells.

Authors:  Driss Zoukhri
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

2.  Successful treatment of a patient with primary Sjögren's syndrome with Rituximab.

Authors:  Troels Ring; Maria Kallenbach; Jeppe Praetorius; Søren Nielsen; Birgitte Melgaard
Journal:  Clin Rheumatol       Date:  2005-11-08       Impact factor: 2.980

Review 3.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

4.  Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome.

Authors:  Carol Stewart; Seunghee Cha; Robert M Caudle; Kathleen Berg; Joseph Katz
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

Review 5.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

6.  Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.

Authors:  S-R Nandula; Y M Scindia; P Dey; H Bagavant; U S Deshmukh
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 7.  Active agents, biomaterials, and technologies to improve biolubrication and strengthen soft tissues.

Authors:  Benjamin G Cooper; Ara Nazarian; Brian D Snyder; Mark W Grinstaff
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

8.  IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.

Authors:  Cuong Q Nguyen; Jue-hua Gao; Hyuna Kim; Daniel R Saban; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 9.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

10.  Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.

Authors:  Jian Zuo; Adrienne E G Williams; Yun-Jong Park; Kevin Choi; Annie L Chan; Westley H Reeves; Michael R Bubb; Yun Jong Lee; Kyungpyo Park; Carol M Stewart; Seunghee Cha
Journal:  J Immunol Methods       Date:  2016-07-25       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.